Search clinical trials for: Dasatinib - 1A
Total 1666 results
-
Georgetown UniversityGlaxoSmithKlineCompletedHead and Neck Cancer | Colorectal Cancer | Lung CancerUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingFrailty | Childhood CancerUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
Tragara Pharmaceuticals, Inc.Terminated
-
Beijing HospitalChinese Society of Clinical OncologyRecruiting
-
Centre Leon BerardBoehringer IngelheimCompletedHead and Neck Squamous Cell CarcinomaFrance
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
University of Alabama at BirminghamGlaxoSmithKlineTerminatedOvarian CancerUnited States
-
Shahid Beheshti University of Medical SciencesUnknown
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel
-
Indiana UniversityGlaxoSmithKlineTerminatedDuctal Carcinoma in SituUnited States
-
GlaxoSmithKlineWithdrawnHealthy SubjectsUnited States
-
University Hospital, BordeauxTerminatedBladder Carcinoma | Cystectomy | Infiltrative Bladder CarcinomaFrance
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
University of Dublin, Trinity CollegeRoyal Liverpool University Hospital; Liverpool John Moores UniversityUnknownSchizophrenia | Schizoaffective DisorderIreland
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
Nanfang Hospital of Southern Medical UniversityRecruitingLeukemia | Leukemia, B-cell | Leukemia, Acute | Leukemia, LymphoblasticChina
-
Mayo ClinicEnrolling by invitation
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
GlaxoSmithKlineCompleted
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic LeukemiaChina
-
Eiger BioPharmaceuticalsActive, not recruitingHepatitis Delta VirusUnited States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina
-
Duke UniversityBristol-Myers SquibbTerminatedPancreatic Adenocarcinoma | Refractory Solid TumorsUnited States
-
AA SecordCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingGestational Trophoblastic NeoplasiaChina
-
Shanghai Chest HospitalUnknownRecurrence | Metastasis | Esophageal Squamous Cell Carcinoma | ApatinibChina
-
Boehringer IngelheimApproved for marketing
-
Jian FangPeking University First Hospital; Peking University Third Hospital; The Second...Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Fudan UniversityCompleted
-
BiogenCompleted
-
Stanford UniversityKite PharmaRecruitingLymphoblastic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple Indications CancerFrance, Poland
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia | Dasatinib | BCR-ABLChina
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
BiogenRecruitingMultiple SclerosisUnited States, Germany